Transcriptional and Post-Translational Control Mechanisms for EphB4 Expression in Physiology and Cancer Disease.
Journal
Critical reviews in eukaryotic gene expression
ISSN: 1045-4403
Titre abrégé: Crit Rev Eukaryot Gene Expr
Pays: United States
ID NLM: 9007261
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
17
2
2022
Statut:
ppublish
Résumé
EphB4 is a membrane tyrosine kinase receptor involved in a number of physiologic and pathologic conditions, cancer being the one drawing the highest attention. In mammalians, EphB4 regulates blood vessel growth and differentiation. EphB4 also mediates a number of cancer promoting effects including angiogenesis, invasion, and metastasis. Its effects have been linked to both EphrinB2-dependent and to EphrinB2-independent mechanisms. In spite of its emerging role in physiology and disease, the regulation of EphB4 cellular expression has been poorly described until recently. The present mini-review summarizes the latest findings on EphB4 regulation at the transcriptional and post-transcriptional level and discusses the biologic implications of such novel findings. Perspective on the scenarios opened by such findings and the open questions in EphB4 research is also provided.
Identifiants
pubmed: 34347982
pii: 3b40abcc31226ddb,501dc37f7f1bf0d9
doi: 10.1615/CritRevEukaryotGeneExpr.2021037928
doi:
Substances chimiques
Insulin-Like Growth Factor II
67763-97-7
Receptor, EphB4
EC 2.7.10.1
Receptor, Insulin
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM